Ambu A/S
Ambu A/S (AMBFF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ambff · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Ambu A/SYou AMBFF | $2.6B | N/A | — | — |
 Amplifon S.p.A. AMFPF | $2.6B | 32.84x | +49.4% | $0.40 |
 Ansell Limited ANSLF | $2.8B | 25.74x | +17.1% | $0.70 |
 Bumrungrad Hospital Public Company Limited BUGDF | $3.8B | 18.03x | -18.0% | $9.44 |
 Bumrungrad Hospital Public Company Limited BUHPF | $4.3B | 18.86x | -14.2% | $9.44 |
 GN Store Nord A/S GGNDF | $2.1B | 23.62x | +7.5% | $4.47 |
 MediPal Holdings Corporation MAHLY | $3.9B | 12.80x | -41.8% | $219.14 |
Industry Average 6 peers with valid PE | — | 21.98x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Ambu A/S (AMBFF) measures how much investors pay for each dollar of the company's trailing earnings. AMBFF's current PE ratio of N/A is calculated by dividing its stock price of $9.90 by its TTM earnings per share of —.
Frequently asked questions
AMBFF pe ratio · 6 questionsAMBFF's current PE ratio is N/A as of 2026-06-10, based on a stock price of $9.90 and TTM EPS of —. Data sourced from Financial Modeling Prep via AMBFF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Ambu A/S SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10